NCT06684743

Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2024-11-18Est. Completion: 2028-05

Enrollment target: 690,000 participants

Locations

Center for Translational Cardiology and Pragmatic Randomized Trials Department of Cardiology Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
Danske Lægers Vaccinations Service, Søborg, Denmark
General Public Health Directorate of Galician Health Service, Santiago de Compostela, A Coruña, Spain

RSV Immunization

The primary objective of this study is to determine the nirsevimab immunization rate in eligible infants in their first …

Prague, CzechiaEst. completion Jul 17, 2026

Respiratory Syncytial Virus Infections

The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospita…

Los Angeles, United StatesEst. completion Dec 30, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.